Zimmer Biomet Holdings, Inc.
Here’s whether Zimmer Biomet Holdings, Inc. (ZBH) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bearish.
Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-1.20% over 10 days); RSI 26 — oversold; weak 1-year return of -18.6%; rising volume on a downtrend (distribution, 1.41x avg). Currently 23.4% off its 52-week high. Score: -6/7.
ZBH is trading below its 200-day MA ($94.90) — a key warning sign the longer-term trend is under pressure. An RSI of 26.4 has dropped into oversold territory, which has historically preceded short-term bounces. The 1-year return of -18.6% compares to +27.9% for SPY (trailed the market by 46.5%). The current 23.4% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.